Trials / Withdrawn
WithdrawnNCT02047422
A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To compare the effectiveness and safety of diuretics add-on strategy in chronic heart failure patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Furosemide | furosemide (doubling previous furosemide dose) |
| DRUG | metolazone | metolazone (add 2.5mg qod) |
| DRUG | furosemid/spironolactone | spironolactone (doubling previous spironoalctone dose or add 12.5mg BID if previous non-user) |
| DRUG | metolazone/spironolactone | no spironolactone (maintaining previous spironolactone dose or not add spironolactone if previous non-user) |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2014-01-28
- Last updated
- 2016-09-07
Source: ClinicalTrials.gov record NCT02047422. Inclusion in this directory is not an endorsement.